Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-28 Sale | 2022-03-02 9:12 pm | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer | 3,946 | $2.1548 | $8,503 | 139,954 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 4:11 pm | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer | 5,833 | $2.2862 | $13,335 | 33,067 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-12 Option Award | 2022-05-16 4:04 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer | 150,000 | $0 | 219,954 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:12 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer | 110,833 | $0 | 139,954 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:06 pm | N/A 2031-02-26 | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer | 70,200 | $0 | 83,100 (Direct) | View |
Ownership | 2021-01-28 5:03 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer | 0 | $0 | 54,900 (Direct) | View |